32 Results
Sort By:
Published on November 17, 2022
Chemicals in the breath of patients admitted to hospital can identify which underlying cardiorespiratory disease they are suffering from, research suggests. Exhaled volatile organic compounds were able to distinguish heart failure, asthma, chronic obstructive pulmonary disease (COPD) and pneumonia, according to the study published in Science Translational Medicine. The “breathomics”…
Published on October 7, 2022
Big data and artificial intelligence have been used to identify already approved or candidate drugs that could be used to treat new COVID-19 variants, according to work from a team at Michigan State University. Their research was published in the journal iScience. Finding new ways to treat the novel coronavirus and its ever-changing…
Published on August 3, 2022
Chronic Obstructive Pulmonary Disease, or COPD, that results in emphysema or chronic bronchitis is the third leading cause of death worldwide but burden of disease is not shared equally between the sexes. Traditionally, men were more likely to be diagnosed but over the past two decades women have been catching…
Published on June 15, 2022
By Susan Wood Susan Wood We are experiencing a worldwide lung crisis. Lung disease mortality rates are much higher than for heart disease, stroke or cancer, and global economic burden across all respiratory diseases is more than $1.3 billion annually.¹ Lung disease certainly deserves more attention…
Published on April 29, 2022
New data analysis from the Veterans Affairs Million Veteran Program (MVP) has uncovered genetic links between COVID-19 severity and certain medical conditions it can cause, including venous embolism and thrombosis, type 2 diabetes, ischemic heart disease, and neutropenia. Identifying these shared variants could improve understanding of COVID-19 and point to…
Published on February 16, 2022
Larisa Cavallari,University of FloridaCollege of Pharmacy When University of Florida (UF) Health started recommending genotyping to guide clopidogrel prescribing about ten years ago it was a “life or death issue,” explains Larisa Cavallari, professor of Pharmacotherapy and Translational Research at UF. The drug is administered after…
Published on January 28, 2022
A new atlas of the cells in the COPD-afflicted lung has been generated, identifying those cells and pathways that may contribute to the reduced lung function and inflammation characteristic of this disease and that could lead to new therapies. Yale School of Medicine researchers found that genes known to be…
Published on September 10, 2021
Research suggests that common medications can accumulate in gut bacteria, altering bacterial function and potentially reducing the effectiveness of the drugs. The gut microbiome is known to play a role in modulating the availability and efficacy of therapeutic drugs. However, the work of systematically mapping bacteria-drug interactions is in its…
Published on April 1, 2021
Research continues to find that the effects of COVID-19 may linger long after hospital discharge. In the latest study, researchers from in England found increased rates of organ damage, or multiorgan dysfunction, in a study of patients discharged from NHS hospitals after COVID-19. Published in The BMJ, the risk for…
Published on December 15, 2020
Researchers in the United States and China have recently released data from a study of the oral microbiome suggesting that the type and abundance of bacteria found in the mouth may be linked to lung cancer risk in nonsmokers. The study, which Albert Einstein College of Medicine assistant professor,…
Published on November 20, 2020
Chronic obstructive pulmonary disease (COPD) is a group of diseases including emphysema and chronic bronchitis that cause airflow restriction and other breathing-related problems. The Centers for Disease Control (CDC) estimates that COPD, the third highest cause of death around the world, more than 16 million Americans. In the United States,…
Published on June 1, 2020
US researchers have analyzed the available literature on COVID-19 infections to assess factors linked with severe cases and to inform medical professionals about drugs that could be repurposed to treat the disease. Since the end of 2019, the SARS-CoV-2 virus behind COVID-19 has spread across the globe in a way…
Published on April 10, 2020
A new study from investigators at Brigham and Women’s Hospital and Harvard Medical School sheds new light on the risk of developing long-term diseases and overall human lifespan. The researchers found that the combined effects of rare, damaging mutations present at birth have a negative impact on healthspan and longevity.…
Published on April 9, 2020
The results of research by University of British Columbia scientists suggest that giving up smoking could lessen the chance that an infection with SARS-CoV-2 coronavirus will lead to severe COVID-19 disease. Their studies found that the lung cells of people who are current cigarette smokers, and individuals with chronic obstructive…
Published on February 5, 2019
SQI Diagnostics will partner with University Health Network (UHN) to create and license rapid multiplexed protein assays and a point-of-care (POC) diagnostic device designed to help transplant surgeons assess the suitability of lungs and other organs for transplantation, through a collaboration whose value was not disclosed. SQI said it will…